Cargando…

Berberine: A Promising Treatment for Neurodegenerative Diseases

Berberine, as a natural alkaloid compound, is characterized by a diversity of pharmacological effects. In recent years, many researches focused on the role of berberine in central nervous system diseases. Among them, the effect of berberine on neurodegenerative diseases has received widespread atten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ziqian, Kang, Chenglan, Che, Songtian, Su, Jingyun, Sun, Qihan, Ge, Tongtong, Guo, Yi, Lv, Jiayin, Sun, Zhihui, Yang, Wei, Li, Bingjin, Li, Xin, Cui, Ranji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164284/ https://www.ncbi.nlm.nih.gov/pubmed/35668943 http://dx.doi.org/10.3389/fphar.2022.845591

Ejemplares similares

Berberine produces antidepressant-like effects in ovariectomized mice
por: Fan, Jie, et al.
Publicado: (2017)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
por: Zhao, Fangyi, et al.
Publicado: (2022)

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
por: Zhang, Chaohe, et al.
Publicado: (2020)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2022)

The Role of KLF(4) in Alzheimer’s Disease
por: Cheng, Ziqian, et al.
Publicado: (2018)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

The mechanism of acute fasting‐induced antidepressant‐like effects in mice
por: Cui, Ranji, et al.
Publicado: (2017)

Leptin in depression: a potential therapeutic target
por: Ge, Tongtong, et al.
Publicado: (2018)

Brain–immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders
por: Zhao, Fangyi, et al.
Publicado: (2022)

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
por: Xu, Songbai, et al.
Publicado: (2022)

Role of Leptin in Mood Disorder and Neurodegenerative Disease
por: Zou, Xiaohan, et al.
Publicado: (2019)

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
por: Han, Dong, et al.
Publicado: (2020)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
por: Zhu, Yumeng, et al.
Publicado: (2022)

Rasd2 Mediates Acute Fasting-Induced Antidepressant-Like Effects via Dopamine D2 Receptor Activation in Ovariectomized Mice
por: Cheng, Ziqian, et al.
Publicado: (2023)

Recent Advances in Herbal Medicines for Digestive System Malignancies
por: Sheng, Jiyao, et al.
Publicado: (2018)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

The effects of herbal medicine on epilepsy
por: Liu, Wei, et al.
Publicado: (2017)

Epigenetic Mechanism of Early Life Stress-Induced Depression: Focus on the Neurotransmitter Systems
por: Cheng, Ziqian, et al.
Publicado: (2022)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

Therapeutic potential of berberine against neurodegenerative diseases
por: JIANG, WenXiao, et al.
Publicado: (2015)

Berberine Potentiates Insulin Secretion and Prevents β-cell Dysfunction Through the miR-204/SIRT1 Signaling Pathway
por: Lv, Xiaoyan, et al.
Publicado: (2021)

Pharmacological effects of berberine on mood disorders
por: Fan, Jie, et al.
Publicado: (2018)

The Anticonvulsant Effects of SR 57227 on Pentylenetetrazole-Induced Seizure in Mice
por: Li, Bingjin, et al.
Publicado: (2014)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour
por: Liu, Hanqing, et al.
Publicado: (2019)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
por: Zhang, Shichang, et al.
Publicado: (2022)

Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
por: Ni, Lulu, et al.
Publicado: (2022)

Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo
por: Li, Lei, et al.
Publicado: (2020)

Hydrogen sulfide: A new therapeutic target in vascular diseases
por: Zhu, Cuilin, et al.
Publicado: (2022)

Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells
por: Zhao, Ting, et al.
Publicado: (2022)

Berberine prevents lethal EV71 neurological infection in newborn mice
por: Cui, Guangyi, et al.
Publicado: (2022)

Gender Differences in Depression: Evidence From Genetics
por: Zhao, Lihong, et al.
Publicado: (2020)

Berberine Facilitates Extinction and Prevents the Return of Fear
por: Huang, Shihao, et al.
Publicado: (2022)

Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice
por: Zhao, Luqing, et al.
Publicado: (2021)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
por: Feng, Xinchi, et al.
Publicado: (2021)

Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
por: Cui, Huantian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ggq9f8hqievtk5f91heds90f5q